Brad A Hartl1, Htet S W Ma1, Katherine S Hansen2, Julian Perks3, Michael S Kent2, Ruben C Fragoso3, Laura Marcu1. 1. a Department of Biomedical Engineering , University of California Davis , Davis , CA , USA. 2. b Department of Surgical and Radiological Sciences , University of California Davis School of Veterinary Medicine , Davis , CA , USA. 3. c Department of Radiation Oncology , University of California Davis School of Medicine , Davis , CA , USA.
Abstract
PURPOSE: To provide a comprehensive understanding of how the selection of radiation dose affects the temporal and spatial progression of radiation-induced necrosis in the rat model. MATERIALS AND METHODS: Necrosis was induced with a single fraction of radiation exposure, at doses ranging between 20 and 60 Gy, to the right hemisphere of 8-week-old Fischer rats from a linear accelerator. The development and progression of necrosis in the rats was monitored and quantified every other week with T1- and T2-weighted gadolinium contrast-enhanced MRI studies. RESULTS: The time to onset of necrosis was found to be dose-dependent, but after the initial onset, the necrosis progression rate and total volume generated was constant across different doses ranging between 30 and 60 Gy. Radiation doses less than 30 Gy did not develop necrosis within 33 weeks after treatment, indicating a dose threshold existing between 20 and 30 Gy. CONCLUSION: The highest dose used in this study led to the shortest time to onset of radiation-induced necrosis, while producing comparable disease progression dynamics after the onset. Therefore, for the radiation-induced necrosis rat model using a linear accelerator, the most optimum results were generated from a dose of 60 Gy.
PURPOSE: To provide a comprehensive understanding of how the selection of radiation dose affects the temporal and spatial progression of radiation-induced necrosis in the rat model. MATERIALS AND METHODS:Necrosis was induced with a single fraction of radiation exposure, at doses ranging between 20 and 60 Gy, to the right hemisphere of 8-week-old Fischer rats from a linear accelerator. The development and progression of necrosis in the rats was monitored and quantified every other week with T1- and T2-weighted gadolinium contrast-enhanced MRI studies. RESULTS: The time to onset of necrosis was found to be dose-dependent, but after the initial onset, the necrosis progression rate and total volume generated was constant across different doses ranging between 30 and 60 Gy. Radiation doses less than 30 Gy did not develop necrosis within 33 weeks after treatment, indicating a dose threshold existing between 20 and 30 Gy. CONCLUSION: The highest dose used in this study led to the shortest time to onset of radiation-induced necrosis, while producing comparable disease progression dynamics after the onset. Therefore, for the radiation-induced necrosisrat model using a linear accelerator, the most optimum results were generated from a dose of 60 Gy.
Authors: E Shaw; R Arusell; B Scheithauer; J O'Fallon; B O'Neill; R Dinapoli; D Nelson; J Earle; C Jones; T Cascino; D Nichols; R Ivnik; R Hellman; W Curran; R Abrams Journal: J Clin Oncol Date: 2002-05-01 Impact factor: 44.544
Authors: Xiaoyu Jiang; Carlos J Perez-Torres; Dinesh Thotala; John A Engelbach; Liya Yuan; Jeremy Cates; Feng Gao; Robert E Drzymala; Keith M Rich; Robert E Schmidt; Joseph J H Ackerman; Dennis E Hallahan; Joel R Garbow Journal: Int J Radiat Oncol Biol Phys Date: 2014-07-15 Impact factor: 7.038
Authors: Jeremy D Ruben; Michael Dally; Michael Bailey; Robin Smith; Catriona A McLean; Pasqual Fedele Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-06 Impact factor: 7.038
Authors: Carlos J Perez-Torres; John A Engelbach; Jeremy Cates; Dinesh Thotala; Liya Yuan; Robert E Schmidt; Keith M Rich; Robert E Drzymala; Joseph J H Ackerman; Joel R Garbow Journal: Int J Radiat Oncol Biol Phys Date: 2014-08-04 Impact factor: 7.038
Authors: Xiaoyu Jiang; John A Engelbach; Liya Yuan; Jeremy Cates; Feng Gao; Robert E Drzymala; Dennis E Hallahan; Keith M Rich; Robert E Schmidt; Joseph J H Ackerman; Joel R Garbow Journal: Clin Cancer Res Date: 2014-03-19 Impact factor: 12.531
Authors: Jinyuan Zhou; Erik Tryggestad; Zhibo Wen; Bachchu Lal; Tingting Zhou; Rachel Grossman; Silun Wang; Kun Yan; De-Xue Fu; Eric Ford; Betty Tyler; Jaishri Blakeley; John Laterra; Peter C M van Zijl Journal: Nat Med Date: 2010-12-19 Impact factor: 53.440
Authors: Dana Greene-Schloesser; Mike E Robbins; Ann M Peiffer; Edward G Shaw; Kenneth T Wheeler; Michael D Chan Journal: Front Oncol Date: 2012-07-19 Impact factor: 6.244
Authors: Brad A Hartl; Htet S W Ma; Shamira Sridharan; Katherine S Hansen; Michael S Kent; Fredric Gorin; Ruben C Fragoso; Laura Marcu Journal: Biomed Opt Express Date: 2018-07-05 Impact factor: 3.732
Authors: Sean P Devan; Guozhen Luo; Xiaoyu Jiang; Jingping Xie; Daniel Dean; Levi S Johnson; Manuel Morales-Paliza; Hannah Harmsen; Junzhong Xu; Austin N Kirschner Journal: Adv Radiat Oncol Date: 2022-07-19